Home/Filings/4/0001104659-20-000978
4//SEC Filing

Bergstein Ivan 4

Accession 0001104659-20-000978

CIK 0001264587other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:18 PM ET

Size

11.0 KB

Accession

0001104659-20-000978

Insider Transaction Report

Form 4
Period: 2019-12-23
Bergstein Ivan
DirectorCEO, Pres., Treas., Sec.10% Owner
Transactions
  • Sale

    Common Stock

    2019-12-27$10.48/sh2,446$25,6342,514,773 total
  • Sale

    Common Stock

    2019-12-23$10.58/sh5,225$55,2812,565,576 total
  • Sale

    Common Stock

    2019-12-24$10.97/sh29,613$324,8552,535,963 total
  • Sale

    Common Stock

    2019-12-26$10.75/sh18,744$201,4982,517,219 total
Footnotes (3)
  • [F1]In connection with the vesting of 108,505 shares on December 21, 2019, a total of 56,028 shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 5,225 shares were sold on December 23, 2019; 29,613 shares were sold on December 24, 2019; 18,744 shares were sold on December 26, 2019; and 2,446 shares were sold on December 27, 2019.
  • [F2]Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Of the shares listed, 578,695 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001554767

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:18 PM ET
Size
11.0 KB